Mitochondrial Transplant for Vision Restoration Receives Emergency FDA Authorization

The FDA has granted emergency authorization for a novel mitochondrial transplantation procedure. This cell therapy involved transferring mitochondria from a patient's leg muscle to her eyes to restore vision following a brain hemorrhage. This marks a significant advancement in mitochondrial transplantation, a therapy of growing interest for injury recovery and longevity research.